Official matched intervention · Drug

Thymosin alpha 1 clinical trials

5 selected ClinicalTrials.gov records carrying the official matched intervention Thymosin alpha 1 (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.

Registry records

5 selected records.

Connected peptides

1 profiles.

Source boundary

ClinicalTrials.gov intervention field.

Cross-source journeys

Explore connected peptide records

Across these connected profiles, PeptideScanner carries 30 selected PubMed records and 0 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.

Collection change ledger

Recently changed records on this intervention hub

All recent changes →

These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.

Record added

ClinicalTrials.gov record NCT00711620

PeptideScanner retained ClinicalTrials.gov record NCT00711620 at 2026-11-15T22:10:40.222Z. Its registry update date was 2011-06-14, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
June 14, 2011
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01031966

PeptideScanner retained ClinicalTrials.gov record NCT01031966 at 2026-11-15T22:10:40.222Z. Its registry update date was 2012-03-29, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
March 29, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02867267

PeptideScanner retained ClinicalTrials.gov record NCT02867267 at 2026-11-15T22:10:40.222Z. Its registry update date was 2023-04-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
April 10, 2023
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →